Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017

Abstract

Background Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the trend in CVD incidence, mortality, and mortality-to-incidence ratio (MIR) across the world over 28 years. Methods The age-standardized CVD mortality and incidence rates were retrieved from the Global Burden of Disease (GBD) Study 2017 for both genders and different world super regions with available data every year during the period 1990–2017. Additionally, the Human Development Index was sourced from the United Nations Development Programme (UNDP) database for all countries at the same time interval. The marginal modeling approach was implemented to evaluate the mean trend of CVD incidence, mortality, and MIR for 195 countries and separately for developing and developed countries and also clarify the relationship between the indices and Human Development Index (HDI) from 1990 to 2017. Results The obtained estimates identified that the global mean trend of CVD incidence had an ascending trend until 1996 followed by a descending trend after this year. Nearly all of the countries experienced a significant declining mortality trend from 1990 to 2017. Likewise, the global mean MIR rate had a significant trivial decrement trend with a gentle slope of 0.004 over the time interval. As such, the reduction in incidence and mortality rates for developed countries was significantly faster than developing counterparts in the period 1990–2017 (p < 0.05). Nevertheless, the developing nations had a more rather shallow decrease in MIR compared to developed ones. Conclusions Generally, the findings of this study revealed that there was an overall downward trend in CVD incidence and mortality rates, while the survival rate of CVD patients was rather stable. These results send a satisfactory message that global effort for controlling the CVD burden was quite successful. Nonetheless, there is an urgent need for more efforts to improve the survival rate of patients and lower the burden of this disease in some areas with an increasing trend of either incidence or mortality.

Trend analysis of disability adjusted life years due to cardiovascular diseases: results from the global burden of disease study 2019

“…Finally, Amini et al used the data from the GBD 2017 study to determine the longitudinal association between cardiovascular disease burden (including incidence and mortality rates) and HDI. They found that developed countries had sharper descending slope of incidence and mortality rates than developing countries (19). In a study by Joseph et al, they declared that although the global CVD mortality has decreased in many parts of the world, the absolute number of deaths is growing in some other regions, especially in low and middle income countries (20).…”

Engagement with community liver disease management across the UK: a cross-sectional survey

“…Liver disease is a common and increasing cause of morbidity and premature mortality in the UK and globally (1). This is in contrast to other common chronic diseases such as heart disease where reduction in morbidity and mortality has been seen over the last 50 years (2). The main causes of liver disease in the UK are alcohol related liver disease (ARLD) and non-alcohol related fatty liver disease (NAFLD); which is increasing in parallel with the obesity and Type 2 diabetes (T2DM) epidemics seen in the UK and across the globe (3).…”

Structure and Function of Mitochondria‐Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Cardiovascular Diseases

“…Globally, there were nearly 523.2 million new cases and 18.6 million deaths from CVD in 2019. Its incidence has increased by 17.1% over the past decade [1,2]. In China, CVD is the leading cause of overall death (40% of all disease mortality) [3].…”